Amnestic mild cognitive impairment and incident dementia and Alzheimer's disease in geriatric depression

International Psychogeriatrics

Volumn 26, Issue 12, 2014, Pages 2029-2036

  Steffens, David C ^a   McQuoid, Douglas R ^b   Potter, Guy G ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Dementia; Depression

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; COGNITION; COMPLICATION; DISEASE COURSE; GERIATRIC ASSESSMENT; HIPPOCAMPUS; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PREVALENCE; PROGNOSIS; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; COGNITION; DEPRESSION; DISEASE PROGRESSION; FEMALE; GERIATRIC ASSESSMENT; HIPPOCAMPUS; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PREVALENCE; PROGNOSIS;

EID: 84911432933     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214001446     Document Type: Article

References (36)

1. Alexopoulos, G. S., Meyers, B. S., Young, R. C., Mattis, S. and Kakuma, T. (1993). The course of geriatric depression with "reversible dementia": a controlled study. American Journal of Psychiatry, 150, 1693-1699.
2. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
3. Benton, A. (1974). Revised Visual Retention Test, 4th Edn, New York, NY: The Psychological Corporation.
4. Bhalla, R. K. et al. (2009). Patterns of mild cognitive impairment after treatment of depression in the elderly. American Journal of Geriatric Psychiatry, 17, 308-316.
5. Diniz, B. S., Butters, M. A., Albert, S. M., Dew, M. A. and Reynolds, C. F. 3rd. (2013). Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. British Journal of Psychiatry, 202, 329-335.
6. Folstein, M., Folstein, S. and Fanjiang, G. (2001). Mini-Mental State Examination: Clinical Guide and User's Guide. Lutz, FL: Psychological Assessment Resources.
7. Gabryelewicz, T. M. et al. (2007). The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. International Journal of Geriatric Psychiatry, 22, 563-567.
8. Green, R. C. et al. (2003). Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Archives of Neurology, 60, 753-759.
9. Jorm, A. F. (2001). History of depression as a risk factor for dementia: an updated review. Australian and New Zealand Journal of Psychiatry, 35, 776-781.
10. Kokmen, E., Beard, C. M., Chandra, V., Offord, K. P., Schoenberg, B. S. and Ballard, D. J. (1991). Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology, 41, 1393-1397.
11. Landerman, R., George, L. K., Campbell, R. T. and Blazer, D. G. (1989). Alternative models of the stress buffering hypothesis. American Journal of Community Psychology, 17, 626-642.
12. Lee, J. S., Potter, G. G., Wagner, H. R., Welsh-Bohmer, K. A. and Steffens, D. C. (2007). Persistent mild cognitive impairment in geriatric depression. International Psychogeriatrics, 19, 125-135.
13. Modrego, P. J., and Ferrandez, J. (2004). Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer's type: a prospective cohort study. Archives of Neurology, 61, 1290-1293.
14. Montgomery, S. A. and Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
15. Morris, J. C. et al. (1989). The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159-1165.
16. Nebes, R. D. et al. (2003). Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. Journal of Psychiatric Research, 37, 99-108.
17. Park, B., Park, J. and Jun, J. K. (2013). Cognitive impairment, depression, comorbidity of the two and associated factors among the early sixties in a rural Korean community. PLoS ONE, 8, e79460.
18. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308.
19. Reding, M., Haycox, J. and Blass, J. (1985). Depression in patients referred to a dementia clinic: a three-year prospective study. Archives of Neurology, 42, 894-896.
20. Richard, E. et al. (2013). Late-life depression, mild cognitive impairment, and dementia. JAMA Neurology, 70, 374-382.
21. Robins, N., Helzer, J. E., Croughan, J. and Ratcliff, K. S. (1981). National Institute of Mental Health diagnostic interview schedule. Archives of General Psychiatry, 38, 381-389.
22. Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Geda Y. E. and Lyketsos, C. G. (2013). The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer's disease. American Journal of Geriatric Psychiatry, 21, 685-695.
23. Saunders, A. M. et al. (1993). Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
24. Sheline, Y. I. et al. (2006). Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biological Psychiatry, 60, 58-65.
25. Speck, C. E. et al. (1995). History of depression as a risk factor for Alzheimer's disease. Epidemiology, 6, 366-369.
26. Steffens, D. C., Plassman, B. L., Helms, M. J., Welsh-Bohmer, K. A., Saunders, A. M. and Breitner, J. C. (1997). A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biological Psychiatry, 41, 851-856.
27. Steffens, D. C. et al. (1999). The effect of major depression on functional status in patients with coronary artery disease. Journal of the American Geriatrics Society, 47, 319-322.
28. Steffens, D. C. et al. (2000). Hippocampal volume in geriatric depression. Biological Psychiatry, 48, 301-309.
29. Steffens, D. C. et al. (2002). Hippocampal volume and incident dementia in geriatric depression. American Journal of Geriatric Psychiatry, 10, 62-71.
30. Steffens, D. C. et al. (2004). Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study. Journal of Geriatric Psychiatry and Neurology, 17, 202-211.
31. Steffens, D. C. et al. (2007). Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. American Journal of Geriatric Psychiatry, 15, 839-849.
32. Steffens, D. C. and Potter, G. G. (2008). Geriatric depression and cognitive impairment. Psychological Medicine, 32, 163-175.
33. Steffens, D. C., McQuoid, D. R., Payne, M. E. and Potter, G. G. (2012). Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. American Journal of Geriatric Psychiatry, 19, 4-12.
34. Taylor, W. D., Steffens, D. C. and Krishnan, K. R. (2006). Psychiatric disease in the twenty-first century: the case for subcortical ischemic depression. Biological Psychiatry, 60, 1299-1303.
35. Wechsler, D. (1987). Wechsler Memory Scale-Revised Manual. San Antonio: Psychological Corporation.
36. Yuspeh, R. L., Vanderploeg, R. D. and Kershaw, A. J. (1998). CERAD praxis memory and recognition in relation to other measures of memory. The Clinical Neuropsychologist, 12, 468-474.